VRTX vs XRAY · P/E 30, rev $12.00B vs rev $3.68B
Vertex Pharmaceuticals Inc (VRTX) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Latest reported XRAY revenue for 2025-12-31 was $3.68B. Net income was -$598.0M. Revenue was down 3.0% from 2024-12-31 to 2025-12-31. XRAY currently screens at market cap $2.01B.
VRTX currently screens at market cap $106.87B and trailing P/E 29.7. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the VRTX and XRAY stock pages for the full models.
Not investment advice.